Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma

Table 1 The relationship between expression level of DLC2 protein and clinicopathological parameters for 53 cases of HCC specimen.

Clinicopathological parameters	No. of patients	Expression of DLC2 protein	P value
Sex
Male	46	0.41 ± 0.08	0.49
Female	7	0.39 ± 0.06
Liver cirrhosis
Present	32	0.39 ± 0.04	0.78
Absent	21	0.40 ± 0.07
Hepatitis virus infection
Present	47	0.41 ± 0.04	0.72
Absent	6	0.40 ± 0.05
Capsule formation
Present	27	0.40 ± 0.04	0.63
Absent	26	0.39 ± 0.06
Tumor nodule
≥ 2	35	0.42 ± 0.10	0.23
< 2	18	0.39 ± 0.06
Cell differentiation*
I ~ II	24	0.42 ± 0.06	0.02**
III ~ IV	29	0.38 ± 0.05
Vein invasion
Present	26	0.41 ± 0.09	0.13
Absent	27	0.39 ± 0.13
Extrahepatic metastasis
Present	11	0.40 ± 0.06	0.34
Absent	42	0.39 ± 0.08
Tumor size
> 5 cm	38	0.41 ± 0.06	0.57
≤ 5 cm	15	0.40 ± 0.09

ISSN: 1471-2407